Endovascular treatment for posterior epistaxis: should it still be considered a last-resort option? A literature review - Summary - MDSpire

Endovascular treatment for posterior epistaxis: should it still be considered a last-resort option? A literature review

  • By

  • Hector R. Martinez

  • Daniel F. Aguilera-Maldonado

  • Andrea Paola Sanchez-Cantu

  • Patricia Maria Orviz-Ortiz

  • Oscar I. Paz-Sanchez

  • Nerea Martin del Campo

  • Carlos Cuilty-Siller

  • Karla Santos-Santillan

  • Jorge Arechavaleta Santos

  • Oscar Gutierrez Trevino

  • Beatriz Elena Perez-Martinez

  • Jose A. Figueroa-Sanchez

  • April 7, 2026

  • 0 min

Share

Objective:

To provide a comprehensive overview of posterior epistaxis, focusing on its vascular anatomy and the role of endovascular treatment, emphasizing its impact on treatment outcomes.

Key Findings:
  • Posterior epistaxis is challenging due to variable etiologies and complex vascular anatomy.
  • Endovascular treatment is feasible and safe, requiring thorough angiographic assessment prior to intervention.
  • Current guidelines still classify endovascular therapy as a last-resort option, which may hinder timely intervention.
Interpretation:

Endovascular therapy should be reconsidered as a viable option for posterior epistaxis rather than being reserved for intractable cases, given its effectiveness and safety profile supported by recent studies.

Limitations:
  • The review is based on existing literature, which may have inherent biases.
  • Variability in clinical practice and guidelines may affect the generalizability of findings, and publication bias may influence the perceived effectiveness of treatments.
Conclusion:

A comprehensive approach, including angiography, can enhance treatment outcomes for posterior epistaxis, and endovascular therapy should be more widely accepted as a primary treatment option, necessitating a shift in clinical guidelines.

Original Source(s)

Related Content